In recent months, Google Ads has implemented substantial changes to its platform and policies. The advertising juggernaut eliminated Expanded Text Ads, updated Smart Shopping campaigns to Performance Max, updated ad accounts to data-driven attribution, and announced that the much-feared, often talked about cookie-less browsing world won’t arrive until 2024.

One of the less-talked-about changes was the May 9^th announcement that Google would alter the Healthcare and Medical policy and that beginning on July 11, 2022, cell and gene therapy ads would be allowed. This update was noted by many marketers who had run headlong into Google’s strictures on medical advertising, which only became stricter during the Covid pandemic. But was this new policy going to relieve a long-time headache for medical ads?